1887

Journal of General Virology header logo

Volume 40, Issue 2

Sensitivity of the Transforming and Replicative Functions of Epstein-Barr Virus to Inhibition by Phosphonoacetate Free

Abstract

SUMMARY

Disodium, phosphonoacetate (PA), at concentrations of 50 to 200 µg/ml, which still allowed continued growth of the EB virus-transformed B95-8 cell line on a routine culture regimen, was able to inhibit the production of virus capsid antigen and of virus particles by these cells down to very low but finite levels which persisted despite prolonged treatment. Further experiments measured the effects of these same drug concentrations on the EB virus-induced transformation of foetal cord blood lymphocytes and on the colony forming ability of already established EB virus-transformed foetal cell lines; in both types of culture, doses of PA up to and including 50 µg/ml did not affect cell growth within the 8-week observation period, whereas doses of 100 µg/ml and above were increasingly inhibitory. The cell lines established by EB virus-induced transformation in the continual presence of PA at 50 to 150 µg/ml contained multiple copies of the virus genome per cell just as did the corresponding cell lines established in control medium. The results argue against the existence of any PA-sensitive event unique to the EB virus-induced transformation process.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1978
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-40-2-409
1978-08-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/40/2/JV0400020409.html?itemId=/content/journal/jgv/10.1099/0022-1317-40-2-409&mimeType=html&fmt=ahah

References

  1. Boyum A. 1968; Separation of leucocytes from blood and bone marrow. Scandinavian Journal of Clinical and Laboratory Investigation 21: (suppl.) 97
     [Google Scholar]
  2. Epstein M. A., Achong B. G., Barr Y. M., Zajac B., Henle G., Henle W. 1966; Morphological and virological investigations on cultured Burkitt tumour lymphoblasts (strain Raji). Journal of the National Cancer Institute 37:547–559
     [Google Scholar]
  3. Ernberg I., Klein G., Kourilsky F. M., Silvestre D. E. 1974; Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence. Journal of the National Cancer Institute 53:61–65
     [Google Scholar]
  4. Gerber P. 1972; Activation of Epstein-Barr virus by 5-bromodeoxyuridine in ‘virus-free’ human cells. Proceedings of the National Academy of Sciences of the United States of America 69:83–85
     [Google Scholar]
  5. Gergely L., Klein G., Ernberg T. 1971; Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography. Virology 45:22–29
     [Google Scholar]
  6. Greaves M. F., Brown G., Rickinson A. B. 1975; Epstein-Barr virus binding sites on lymphocyte populations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis. Clinical Immunology and Immunopathology 3:514–524
     [Google Scholar]
  7. Hampar B., Derge J. G., Martos L. M., Walker J. L. 1972; Synthesis of Epstein-Barr virus after activation of the viral genome in a ‘virus-negative’ human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine. Proceedings of the National Academy of Sciences of the United States of America 69:78–82
     [Google Scholar]
  8. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology gi:1248–1256
     [Google Scholar]
  9. Henle W., Diehl V., Kohn G., Zur Hausen H., Henle G. 1967; Herpes-type virus and chromosome marker in normal leucocytes after growth with irradiated Burkitt cells. Science 157:1064–1065
     [Google Scholar]
  10. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. 1970; Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169:188–190
     [Google Scholar]
  11. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R., Grace J. T. 1967; Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. Journal of Virology 1:1045–1051
     [Google Scholar]
  12. Huang E.-S., Huang C.-H., Huong S.-M., Selgrade M. 1976; Preferential inhibition of herpes-group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity. The Yale Journal of Biology and Medicine 49:93–98
     [Google Scholar]
  13. Jondal M., Klein G. 1973; Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus (EBY) receptors on B lymphocytes. Journal of Experimental Medicine 138:1365–1378
     [Google Scholar]
  14. Klein G., Clifford P., Klein E., Stjernsward J. 1966; Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proceedings of the National Academy of Sciences of the United States of America 55:1628–1635
     [Google Scholar]
  15. Leinbach S. S., Reno J. M., Lee L. F., Isbell A. F., Boezi J. A. 1976; Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase. Biochemistry 15:426–430
     [Google Scholar]
  16. Lemon S. M., Hutt L. M., Pagano J. S. 1978; Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of PAA on nucleic acid. Submitted for publication
     [Google Scholar]
  17. Lindahl T., Adams A., Bjursell G., Bornkamm G. W., Kaschka-Dierich C., Jehn U. 1976; Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell lines. Journal of Molecular Biology 102:511–530
     [Google Scholar]
  18. Mao J. C.-H., Robishaw E. E., Overby L. R. 1975; Inhibition of DNA polymerase from herpes simplex virus-infected Wi-38 cells by phosphonoacetic acid. Journal of Virology 15:1281–1283
     [Google Scholar]
  19. Miller G., Lipman M. 1973; Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences of the United States of America 70:190–194
     [Google Scholar]
  20. Miller R. L., Glaser R., Rapp F. 1977; Studies of an Epstein-Barr virus-induced DNA polymerase. Virology 76:494–502
     [Google Scholar]
  21. Moss D. J., Pope J. H. 1972; Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro . Journal of General Virology 17:233–236
     [Google Scholar]
  22. Nyormoi O., Thorley-Lawson D. A., Elkington J., Strominger J. L. 1976; Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. Proceedings of the National Academy of Sciences of the United States of America 73:1745–1748
     [Google Scholar]
  23. Overby L. R., Robishaw E. E., Schleicher J. B., Rueter A., Shipkowitz N. L., Mao J. C.-H. 1974; Phosphonoacetic acid: inhibitor of herpes simplex virus. Antimicrobial Agents and Chemotherapy360–365
     [Google Scholar]
  24. Pattengale P. K., Smith R. W., Gerber P. 1973; Selective transformation of B lymphocytes by EB virus. Lancet ii:93–94
     [Google Scholar]
  25. Pope J. H., Horne M. K., Scott W. 1968; Transformation of foetal human leucocytes in vitro by filtrates of human leukaemic cell line containing herpes-like virus. International Journal of Cancer 3:857–866
     [Google Scholar]
  26. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent end points. American Journal of Hygiene 27:493–497
     [Google Scholar]
  27. Reedman B. M., Klein G. 1973; Cellular localisation of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
     [Google Scholar]
  28. Rickinson A. B., Crawford D. H., Epstein M. A. 1977a; Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients. Clinical and Experimental Immunology 28:72–79
     [Google Scholar]
  29. Rickinson A. B., Finerty S., Epstein M. A. 1977b; Mechanism of the establishment of Epstein-Barr virus genome-containing lymphoid cell lines from infectious mononucleosis patients: studies with phos-phoacetate. International Journal of Cancer 20:861–868
     [Google Scholar]
  30. Rickinson A. B., Finerty S., Epstein M. A. 1977c; Inhibition by phosphonoacetate of the in vitro outgrowth of Epstein-Barr virus genome-containing cell lines from the blood of infectious mononucleosis patients. In Oncogenesis and Herpesviruses vol III (in the press) Lyon: IARC;
     [Google Scholar]
  31. Rickinson A. B., Jarvis J. E., Crawford D. H., Epstein M. A. 1974; Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis. International Journal of Cancer 14:704–715
     [Google Scholar]
  32. Sugawara K., Mizuno F., Osato T. 1972; Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines. Nature New Biology 239:242–243
     [Google Scholar]
  33. Summers W. C., Klein G. 1976; Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. Journal of Virology 18:151–155
     [Google Scholar]
  34. Thorley-Lawson D., Strominger J. L. 1976; Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid. Nature, London 263:332–334
     [Google Scholar]
  35. Yajima Y., Tanaka A., Nonoyama M. 1976; Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid. Virology 71:352–354
     [Google Scholar]
  36. Zur Hausen H., Diehl V., Wolf H., Schulte-Holthausen H., Schneider U. 1972; Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nature New Biology 237:189–190
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-40-2-409
Loading
Sensitivity of the Transforming and Replicative Functions of Epstein-Barr Virus to Inhibition by Phosphonoacetate
J. Gen. Virol. 40, 409 (1978); https://doi.org/10.1099/0022-1317-40-2-409
/content/journal/jgv/10.1099/0022-1317-40-2-409
/content/journal/jgv/10.1099/0022-1317-40-2-409
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error